No mRNA Me-Too? CureVac Spies 2021 Launch For COVID-19 Vaccine
EU Backing Gives Company Options
Pfizer and Moderna have set a high bar, but CureVac's mRNA contender is buoyed by a big EU procurement deal and a favorable stability profile as it heads into pivotal trials.
